House Passes CHIPS Act

President Biden signed into law the $280 billion CHIPS (Creating Helpful Incentives to Produce Semiconductors) and Science Act, a bill that would subsidize domestic semiconductor manufacturing and invest billions in science and technology innovation, in a bid to strengthen the United States’ competitiveness and self-reliance in what is seen as a keystone industry for economic and…

Read More

Senate Considers Drug Pricing Controls Legislation

In the waning days before the August recess, Senate Democrats are pushing legislation with anti-science drug price controls, as part of a so-called reconciliation bill. The legislation could undercut its own goals by depriving drugmakers of incentives for developing blockbuster medicines, plus lower-cost biosimilars and generics, several analysts and industry groups have warned. Predictions are that…

Read More